Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease

  • Kyota Fujita,

    Affiliation Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

  • Toshihiro Seike,

    Affiliation Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

  • Noriko Yutsudo,

    Affiliation Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  • Mizuki Ohno,

    Affiliation Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  • Hidetaka Yamada,

    Affiliation Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  • Hiroo Yamaguchi,

    Affiliation Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  • Kunihiko Sakumi,

    Affiliation Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  • Yukiko Yamakawa,

    Affiliation Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

  • Mizuho A. Kido,

    Affiliation Department of Oral Anatomy and Cell Biology, Graduate School of Dental Sciences, Kyushu University, Fukuoka, Japan

  • Atsushi Takaki,

    Affiliation Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

  • Toshihiko Katafuchi,

    Affiliation Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

  • Yoshinori Tanaka,

    Affiliation R&D Center, Home Appliances Manufacturing Business Unit, Panasonic Electric Works Co., Ltd., Osaka, Japan

  • Yusaku Nakabeppu ,

    Contributed equally to this work with: Yusaku Nakabeppu, Mami Noda

    Affiliation Division of Neurofunctional Genomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  • Mami Noda

    Contributed equally to this work with: Yusaku Nakabeppu, Mami Noda

    noda@phar.kyushu-u.ac.jp

    Affiliation Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan

Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease

  • Kyota Fujita, 
  • Toshihiro Seike, 
  • Noriko Yutsudo, 
  • Mizuki Ohno, 
  • Hidetaka Yamada, 
  • Hiroo Yamaguchi, 
  • Kunihiko Sakumi, 
  • Yukiko Yamakawa, 
  • Mizuho A. Kido, 
  • Atsushi Takaki
PLOS
x

Abstract

It has been shown that molecular hydrogen (H2) acts as a therapeutic antioxidant and suppresses brain injury by buffering the effects of oxidative stress. Chronic oxidative stress causes neurodegenerative diseases such as Parkinson's disease (PD). Here, we show that drinking H2-containing water significantly reduced the loss of dopaminergic neurons in PD model mice using both acute and chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The concentration-dependency of H2 showed that H2 as low as 0.08 ppm had almost the same effect as saturated H2 water (1.5 ppm). MPTP-induced accumulation of cellular 8-oxoguanine (8-oxoG), a marker of DNA damage, and 4-hydroxynonenal (4-HNE), a marker of lipid peroxidation were significantly decreased in the nigro-striatal dopaminergic pathway in mice drinking H2-containing water, whereas production of superoxide (O2) detected by intravascular injection of dihydroethidium (DHE) was not reduced significantly. Our results indicated that low concentration of H2 in drinking water can reduce oxidative stress in the brain. Thus, drinking H2-containing water may be useful in daily life to prevent or minimize the risk of life style-related oxidative stress and neurodegeneration.

Introduction

It has been reported that molecular hydrogen (H2) selectively reduces the hydroxyl radical, the most cytotoxic of the reactive oxygen species (ROS), and can thereby effectively protect cells. Thus, inhalation of H2 gas strongly suppressed ischemic and reperfusion brain injury [1], [2] and consumption of water saturated with H2 (H2 water) prevented stress-induced impairments in learning tasks during chronic physical restraint [3] by buffering the effects of oxidative stress or superoxide formation [4]. Oxidative stress, linked to mitochondrial damage, is also a primary cause of Parkinson's disease (PD) [5][7]. PD is regarded as an intractable neurodegenerative disease with pathological changes to dopaminergic neurons in the substantia nigra (SN) and nigro-striatal dopaminergic nerve terminals, leading to movement disorders such as tremor, rigidity and akinesia [8]. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-based PD model has been important in elucidating the molecular cascade of cell death in dopaminergic neurons as well as the discovery of PD genes [9]. MPTP itself is not toxic, and as a lipophilic compound can cross the blood-brain barrier. Once inside the brain, MPTP is metabolized into the toxic cation 1-methyl-4-phenylpyridinium (MPP+) by the enzyme monoamine oxidase B (MAO-B) in glial cells. MPTP has a quite selective ability to cause neuronal death in dopaminergic cells, apparently through a high-affinity uptake process, through a dopamine transporter (DAT) [10], after it has been released from the glial cells. Inside dopaminergic neurons, MPP+ interferes with complex I of the electron transport chain, a component of mitochondrial metabolism, which leads to cell death and causes the buildup of free radicals, toxic molecules that contribute further to cell destruction [11].

Today, antioxidant compounds are widely recognized for the potential therapeutic treatment of oxidative stress diseases. Some antioxidant drugs and antioxidant materials in foods have been tested in the MPTP mouse model [12], [13]. Antioxidants not only in foods but also in drinking water would offer a great advantage over other forms of antioxidant therapy. In fact, it was reported that drinking electrolyzed H2-saturated water showed an effect in reduction of oxidative stress in rats, as measured by urine oxidized guanine and hepatic lipid peroxide [14]. Recently it was also shown that drinking H2-saturated water, instead of inhaling H2 gas, prevents cognitive impairment by reducing oxidative stress [3]. According to Nagata et al. [3], even in drinking water, H2 can be delivered to the blood in minutes.

Using the widely accepted PD model, we have tested the effect of H2-containing drinking water on the MPTP-induced loss of dopaminergic neurons. Here we show that drinking H2 water may potentially offer a great advantage over other forms of antioxidant therapy, particularly for chronic pathological conditions such as PD.

Results

Hydrogen water made by bubbling H2 gas and using electrochemical reaction of magnesium

Hydrogen water (H2 water) could be made by several methods. In the present experiments, H2 water made by two relatively easy and safe ways was tested. The H2 content in H2 water, made by either dissolving electrolyzed hydrogen into pure water (H2 bubbled water) or utilizing electrochemical reaction of magnesium with water (H2/Mg water), declined with a half-time of ∼2 h and almost disappeared after 8 h (Figure 1). The time course of H2 content was similar in H2 bubbled water and H2/Mg water except at 4 and 6 h, suggesting that H2 was better maintained in H2/Mg water, though the mechanism was not clear.

thumbnail
Figure 1. Time-dependent decrease of H2 content in each drinking water and their pH.

Hydrogen water was made by directly bubbling H2 gas produced by electrolysis (H2 bubbled water) or chemical reaction using Mg (Mg/H2 water). **P<0.01 compared to H2 bubbled water. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g001

The effect of H2 water on acute MPTP neurotoxicity

To simply observe the effect of H2 in drinking water, H2-bubbled water was used for acute MPTP neurotoxicity tests. Mice were given H2 water or non-H2 water for 7 days prior to the MPTP administration and kept receiving it until the mice were killed and brains were extirpated. Since the H2 content disappeared within 8 h (Figure 1), water supply was restricted to 8 h per day so that most of the water was taken by the mice during the first few hours of each day. Systemic administration of MPTP caused a significant decrease in the number of dopaminergic neurons in substantia nigra pars compacta (SNpc) (38% of that after saline & non-H2 water) compared to those in saline injection group, as shown by the number of tyrosine hydroxylase (TH)-positive cells (Figure 2A). Dopaminergic fibers in the substantia nigra pars reticulosa (SNpr) were also apparently reduced. In mice treated with H2 water, the loss of dopaminergic neurons in SNpc was about a half of that in mice drinking non-H2 water (54% of saline & non-H2 water) and showed a significant reduction in the loss of neurons in SNpc (Figure 2B). In saline injected groups, there were no apparent effects of H2 on the number of dopaminergic neurons in SNpc (Figure 2A, 2B). This result was also supported by stereological analysis, a better method for unbiased cell counting (Figure 2C, 2D). The number of TH-positive neurons was significantly decreased by MPTP administration, to 40% of controls (4180±309, MPTP & non-H2 water; 10335±491, saline & non-H2 water). However, drinking H2 water significantly attenuated this decrease of neurons by MPTP without any decrease in saline injected mice (7105±325, MPTP & H2 water; 10094±716, saline & H2 water). Morphological observations also supported a lesser decrease of TH-immunoreactivity in both SNpc and SNpr. This rigorous stereological analysis fully supports the results obtained using conventional counting methods. Consequently, the protective effect of H2 was proved by two different counting methods. The effects of H2 water were dose-dependent, with a maximal effect at a much lower concentration (0.08 ppm) than saturated concentration of H2 (1.5 ppm) (Figure 2E).

thumbnail
Figure 2. Drinking H2 bubbled water reduced loss of dopaminergic neurons in substantia nigra induced by acute injection of MPTP.

(A) Representative photomicrographs illustrating tyrosine hydroxylase (TH)-staining in substantia nigra (SN) of indicated treatment animal groups. TH-staining from mice with saline injection drinking non-H2 water or H2-bubbled water and those from MPTP-injected mice drinking non-H2 water or H2 bubbled water. Scale; 200 µm. (B) Average number of TH-positive neurons in SN pars compacta (SNpc), measured in 20 µm coronal sections (n = 4–6). (C) Representative photomicrographs illustrating TH immunoreactivity in the SN of indicated treatment animal groups. Staining is more intense than in (A) because of increased section thickness (30 µm) required for stereological analysis. Scale; 200 µm. (D) Quantification of TH-positive neurons by stereology, as described in Materials and Methods. (n = 4 each) (E) TH-positive neurons in SN from mice treated with 4 different concentration of H2 (0.04, 0.08, 0.5, 1.5 ppm) in drinking water (n = 4–6). One-way ANOVA; ###P<0.001 compared to saline with non-H2 water; *P<0.05, **P<0.01 compared to MPTP with non-H2 water. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g002

Mg/H2 water and its effect on acute MPTP model mice

For further experiments, H2/Mg water was used, which was made by a much easier and safer procedure. H2/Mg water contained about 0.08 ppm H2. H2/Mg water showed a similar protective effect as H2-bubbled water on the loss of dopaminergic neurons in acute MPTP model mice. Without MPTP administration, H2/Mg water had no effect on the number of TH-positive cells (195±8; non-H2/Mg water, 194±4; H2/Mg water, Figure 3A, 3C). To test whether or not drinking H2/Mg water was effective even after suffering oxidative stress, we compared two different procedures (Figure 3B); one was giving H2/Mg water 7 days prior to the acute MPTP administration (Figure 3B; shown as i) and the other giving H2/Mg water only after MPTP administration (Figure 3B; shown as ii). The result showed that drinking H2/Mg water reduced the loss of dopaminergic neurons even after MPTP injection (Figure 3B, 3C; 16% & 17% recovery in drinking protocol shown as A&B, respectively). This may imply that drinking H2 water might be effective even after the onset of oxidative stress-induced PD.

thumbnail
Figure 3. Drinking H2/Mg water before and after acute injection of MPTP reduced loss of dopaminergic neurons.

(A) TH-positive dopaminergic neurons in SN. Mice were treated with non-H2 water or H2/Mg water before and after acute MPTP injection. Scale; 200 µm. (B) Schedule for drinking H2 water before (i) and after (ii) MPTP injection. (C) Average number of TH-positive neurons in mice with acute injection of saline or MPTP. One-way ANOVA; ###P<0.001 compared to saline with non-H2 water; *P<0.05, **P<0.01 compared to MPTP with non-H2 water. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g003

Since H2/Mg water was alkaline (pH ∼8.8, Figure 1), we tested the effect of alkalinized water (up to pH 8.8) made by adding Mg(OH)2 to pure water. We also tested the effect of Mg and other metal elements, Al and Zn which might possibly exist in H2/Mg water, by leaving the H2/Mg water for 24 h (degassed H2/Mg water) so that all the H2 had gone. Neither of these solutions had any protective effect against MPTP-derived neurotoxicity (Figure 4A, 4B). Thus, the effect of the H2/Mg water was not due to metal elements or to its alkalinity but to its content of H2.

thumbnail
Figure 4. H2, but not Mg ion and alkalinity, protected the neuronal damage from acute MPTP neurotoxicity.

(A) TH-positive neurons in SN in mice drinking pure water (non-H2 water), Mg(OH)2 water or degassed H2/Mg water. Neither Mg(OH)2 water nor degassed H2/Mg water had significant effect on MPTP neurotoxicity. (B) Average number of TH-positive neurons in SNpc in mice drinking non-H2 water, Mg(OH)2 water, and degassed H2/Mg water. (C) The amount of MPP+ in striatum in mice drinking H2/Mg water (white) and pure water (black) was not significantly different. MPP+ was measured 3 h after the last MPTP administration, when the concentration of MPTP reached maximum. One-way ANOVA. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g004

MPTP is converted into MPP+ which is indispensable for MPTP-derived neurotoxicity. We therefore measured the amount of MPP+ in the striatum where it was incorporated by DAT. The amount of MPP+ in the striatum was not significantly different in animals drinking H2 water and non-H2 water (Figure 4C). Therefore, the effect of H2 water against the loss of dopaminergic neurons in SNpc by MPTP was not related to the metabolism of MPTP.

The effect of H2 water in chronic MPTP infusion model

Despite the lack of parkinsonian symptoms in the acute MPTP model in rodents, probably due to the low level of MAO-B in the rodent brain's capillaries [15], behavioral impairment could be observed in the chronic MPTP infusion model using an osmotic minipump to deliver the MPTP for long period [16]. This could provide a better model for human PD. In this experiment, mice were supplied with H2 water or non-H2 water 7 days prior to the pump implantation and the water supply continued until brain extirpation 28 days later (Figure 5A). Chronic infusion of MPTP induced a loss of TH-positive dopaminergic neuron in SNpc (Figure 5B). In mice drinking H2 water, the loss of TH-positive cells (76% of control: saline & non-H2 water) was less than that in mice drinking non-H2 water (56% of control: saline & non-H2 water) (Figure 5C). For the behavioral test, the ambulation scores in the open-field test were compared. Using the slightly modified open-field test reported previously [16], the ambulation score was expressed as percentage of that obtained in the first trial. Drinking H2 water did not show any significant change in the ambulation score in mice with saline infusion (69±3% with non-H2 water and 73±6% with H2 water, respectively). The ambulation score in mice with chronic MPTP infusion with non-H2 water was 40±4%, while in mice with H2 water was 54±4% (Figure 5D). Other behavioral tests, for example the rotarod test and tail suspension test, were also examined but no significant effects were observed following chronic MPTP infusion (data not shown).

thumbnail
Figure 5. Drinking H2/Mg water attenuated neurotoxicity and behavioral phenotype induced by chronic infusion of MPTP.

(A) Schedule for continuous infusion of MPTP and behavioral observation. Mice started to drink non-H2 water or H2/Mg water 1 week before infusion of minipump. The 1st open-field test was performed in the morning of pump infusion. The 2nd test was performed 28 days after pump infusion. (B) TH-staining from mice with saline-infusion drinking non-H2 water (I) or H2/Mg water (II) and those from mice with MPTP-infusion drinking non-H2 water (III) or H2/Mg water (IV). (C) Average number of TH-positive neurons in mice with saline- or MPTP-infusion (n = 6). Brain samples were obtained from six 20 µm coronal SN sections. (D) Suppression of open-field activity by chronic infusion of MPTP was partially recovered by drinking H2/Mg water. Relative ambulation score at the 2nd measurement was expressed as percentage of the 1st measurement (n = 6 for each group). One-way ANOVA; ###P<0.001 compared to saline with non-H2 water; *P<0.05, **P<0.01 compared to MPTP with non-H2 water. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g005

Hydrogen water reduced 4-HNE production in SN dopaminergic neuron

4-HNE is an aldehyde toxic end product of lipid peroxidation and one of the markers of membrane lipid peroxidation induced by cytotoxic radicals such as •OH [17]. Also, 4-HNE is reported to mediate the induction of neuronal apoptosis in the presence of oxidative stress [18]. In the acute MPTP model, protein level of 4-HNE in midbrain is increased [12], [19]. In saline-injected mice, 4-HNE immunoreactive fluorescence in TH-positive neuron was minimal (Figure 6A, 6B). In contrast, in MPTP-treated mice, 4-HNE fluorescence was increased significantly 24 h after the last injection of MPTP.

thumbnail
Figure 6. H2 water reduced 4-HNE, but not DHE fluorescence in SN after MPTP administration.

(A) Fluorescent images of 4-HNE, DHE, and TH in SN (n = 3∼4). Mice treated with non-H2 water or H2/Mg water with injection of saline or MPTP. All samples were acquired 24 h after administration of saline or MPTP. Scale: 50 µm. (B, C) Quantification of 4-HNE (B) and DHE (C) intensity in TH-positive cells in SN. One-way ANOVA; #P<0.05, ###P<0.001 compared to saline with non-H2 water; ***P<0.001 compared to MPTP with non-H2 water. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g006

In mice drinking hydrogen water, the baseline level of 4-HNE fluorescence was unchanged, but the striking increase in fluorescence following MPTP administration was virtually annulled, to a level that was not significantly above baseline (Figure 6B).

Hydrogen water failed to reduce the production of intracellular superoxide in SN dopaminergic neuron

Intracellular superoxide (O2) was detected by administration of O2 indicator, dihydroethidium (DHE) [20]. When DHE is oxidized by O2, it binds to DNA and a bright red fluorescence is observed within the cell body.

The DHE intensity in TH-positive cell was significantly increased in the acute MPTP-treated mice compared to saline-treated mice (Figure 6A, 6B). Mice drinking hydrogen water appeared to show a slight decrease of DHE fluorescent intensity compared to non-hydrogen water mice with MPTP-injection, but this was not statistically significant (p = 0.21). As for microglia, which is one of the sources of superoxide release in SN, microglia did not show their activation 24 h, but 48 h after MPTP treatment. In mice drinking H2 water, the morphological change of microglia was also observed 48 h, but not 24 h after MPTP administration (Figure S1).

Accumulation of cellular 8-oxoguanine in striatum

MPTP-induced loss of dopaminergic neuron is associated with the accumulation of 8-oxoguanine (8-oxoG) in the nigro-striatal pathway [5]. 8-oxoG is the major form of guanine oxidized by •OH, and is accumulated in both mitochondrial and nuclear DNA [21]. Hence, 8-oxoG is widely used as an index of DNA oxidative stress. The distinction between 8-oxoG accumulation in mitochondrial and nuclear DNA can be made using immunohistochemical techniques [5], [22]. In our study, we investigated the accumulation of mitochondrial 8-oxoG in the striatum, where the dopaminergic nerve terminals end. Mitochondrial 8-oxoG showed significant accumulation in the striatum 24 h after acute MPTP administration. H2 water reduced this accumulation to a level not significantly different from the control (Figure 7A, 7B). At 24 h after acute MPTP administration, microglia in the striatum were activated in mice drinking both H2 and non-H2 water (data not shown), and similarly in the SN 48 h after MPTP administration (Figure S1).

thumbnail
Figure 7. H2 water decreased the accumulation of 8-oxoG in striatum after MPTP administration.

(A) Acute administration of MPTP significantly increased the accumulation of mitochondrial 8-oxoG (I and III) and induced the loss of TH-positive neurons and fibers (V and VII). However, in mice drinking H2/Mg water, no significant 8-oxoG accumulation (II and VI) nor TH-positive staining (VI and VIII) was observed. Brains were extirpated 24 h after administration of saline or MPTP. Scale: 500 µm. (B) Immunoreactive index for 8-oxoG and TH (n = 4 each). One-way ANOVA; ##P<0.01 and ###P<0.001 compared to saline with non-H2 water; ***P<0.001, compared to MPTP with non-H2 water. Error bars represent mean ± SEM.

https://doi.org/10.1371/journal.pone.0007247.g007

Discussion

This study shows that drinking water containing H2 (H2 water) attenuated the acute neurotoxic effects of MPTP on dopaminergic neurons. H2 water was also effective on the behavioral impairment produced by chronic administration of MPTP, the major symptom of Parkinson's disease (PD). We found that low concentration of H2 in drinking water, well below saturating concentrations, showed neuroprotective effects against the MPTP-induced loss of dopaminergic neurons and neuronal fibers in nigro-striatal pathway, and that this could be seen even after the start of the neurotoxic insult. H2 water also reduced the amount of ROS-derived oxidative products such as 4-HNE and 8-oxoG, which would be primary causes of neuronal apoptosis in dopaminergic neurons. Thus, our study may pave the way toward a new neuroprotective strategy using H2 water in PD patients.

PD is a progressive, degenerative disorder of the nervous system, meaning that it becomes increasingly disabling over time. It is a chronic, life-long condition. Various causes have been speculated: dopaminergic neurons can die or become damaged by infection, trauma, or toxins found in the environment, like MPTP. There may be also some genetic links. The impairments by all of these causes are generally related to varying degrees of oxidative stress [23]. Oxidative stress contributes to the cascade leading to dopamine cell degeneration in PD. Studies revealed that several biomarkers of oxidative damage are elevated in SN of PD brain [9]. Also, dopaminergic neurons may be a particularly fertile environment for the generation of ROS, as the metabolism of dopamine produces hydrogen peroxide and superoxide radicals, and auto-oxidation of dopamine produces dopamine-quinone, a molecule that damages proteins by reacting with cysteine residues [9], [24].

Taking these reports into consideration, reducing oxidative stress or oxidative damage would become a potential way to prevent PD. H2 acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals [1][4], [14], [25], [26], either by inhalation or consumption. Although inhalation of H2 may act more rapidly, it is not practical in daily life or suitable for continuous consumption. H2 water is clearly more convenient, and fits well within a normal life-style. The most convenient form of H2 water is H2/Mg water. In our experiments, neither the alkalinity nor the magnesium had any effect but the small amounts of dissolved H2 turned out to have significant neuroprotective and anti-oxidant effects.

As for the concentration of H2, it was reported that H2 dissolved in arterial blood was increased by the inhalation of H2 in proportion to the concentration inhaled, from 0 to 4%, together with O2 and N2O; the amount of H2 dissolved in venous blood was less than that in artery blood, suggesting that H2 had been incorporated into tissues [1]. Recently it was also reported that the blood concentration of H2 which was incorporated from the stomach using water with saturated H2 was 5 µM [3]. We tried to measure the concentration of H2 in rat striatum with cyclic voltammetry analysis using a H2 electrode (Teflon-coated platinum electrode for the cerebral blood flow study, 200 µm in diameter) [27] inserted through a previously-mounted guide-cannula [28] (See Materials and Methods S2). We could detect the change in H2 in the striatum during the inhalation of H2 (Figure S2). It increased immediately when the rats started to inhale the H2 gas and reached a plateau within 10 minutes (0.22 ppm; 110 µM), but decreased soon after stopping inhalation (t1/2 = 343 s; n = 3). However, we could not detect any change in H2 concentration on instilling saturated H2 water into the stomach in anesthetized rats or in free-moving rats drinking H2-water. If there is 160 fold decrease in H2 concentration between stomach and blood [3], there would be an even greater decrease between the H2 concentration in drinking water (maximum 1.5 ppm) and that in striatal tissue. This suggests that the tissue H2 concentration would be below detection level. Therefore, even though tissue H2 would be expected to rise after drinking H2 water, currently there is a technical problem in detecting such low levels.

In the PD model, ROS can be released from both cytosol and mitochondria of DA neuron [29][32]. Administration of MPTP causes its dysfunction via inhibition of complex I, which is associated with the electron transport chain [11]. Subsequent studies have identified abnormalities in complex I activity in PD [9], [33]. Mitochondrial dysfunction causes massive production of ROS, especially O2. At the nerve terminal of dopaminergic neuron in the striatum, where there are abundant mitochondria, more production of O2 is predicted [9]. Furthermore, O2 transforms into •OH by several steps including the Fenton reaction, which is catalyzed by ferrous iron (Fe2+). Fe2+ can react with hydrogen peroxide (H2O2) (produced during oxidative deamination of dopamine) to generate •OH that can damage proteins, nucleic acids, and membrane phospholipids, leading to cellular degeneration [34][36]. We showed that a significant increase in markers characteristic of oxidative damage in the nigro-striatal pathway, such as 4-HNE, mitochondrial 8-oxoG, and DHE, occurred 24 h after MPTP administration. 4-HNE and 8-oxoG are well-known markers for oxidative insult mainly caused by •OH. 4-HNE was observed in membrane surface of TH-positive dopaminergic neuron in SN, and mitochondrial 8-oxoG was accumulated in the striatum over the same period (24 h after MPTP administration). It has been previously reported that mitochondrial 8-oxoG, the •OH -oxidative form of guanine and a marker of DNA damage, is accumulated the striatum of MPTP-injected mice [5]. However, hydrogen water significantly decreased the amount of 4-HNE in the SN and mitochondrial 8-oxoG in the striatum. This indicates that hydrogen acted by reducing the primary production of •OH in the nigro-striatal pathway.

A DHE fluorescence signal is detected when DHE and O2 react and the oxidized DHE is incorporated into DNA. So, DHE is widely used for imaging intracellular O2 both in vitro and in vivo [37][39]. During MPTP neurotoxicity, O2 is released from not only neuronal mitochondria, but also by auto-oxidation of dopamine in dopaminergic neuron [40]. Also, NADPH oxidase in activated microglia is a source of O2 in the nigro-striatal pathway [41]. However, in our experiments, we observed the production of O2 at 24 h, before microglial activation. Although microglia are key players in the release of O2, microglial NADPH activity is enhanced together with microglial activation and the peak of NADPH activity is only observed 48 h after administration of MPTP [42]. In our case, microglia was activated following the degeneration of dopaminergic neurons, not before, as shown in Figure S1. Although some microglia in the SN were activated in 24 h, we can conclude that DHE signals which we observed in 24 h after MPTP injection mostly reflected neuronal O2 production in SN.

In a previous study, hydrogen reduced •OH but not other kinds of reactive oxygen/nitrogen species [1]. However, in vivo, there is little knowledge whether hydrogen shows selective reduction of ROS [4]. In our experiment, DHE intensity was not significantly reduced by hydrogen water in MPTP-treated mice, indicating that hydrogen water showed less or no reduction of O2. This accords with the previous report that hydrogen showed a selective reduction of ROS [1]. On the othet hand, another study has shown that hydrogen water can reduce the amount of O2 in vivo [4]. These opposite results may relate to the different concentrations of hydrogen in drinking water. Our hydrogen water contained a much lower amount of hydrogen than saturated hydrogen water, which may not be enough to reduce O2.

We provided chronic MPTP administration model using osmotic minipump modifying the previous method. However, the number of TH-positive neurons in chronic MPTP model mice was more than acute MPTP model mice. Continuous MPTP infusion model caused less acute toxicity because the peak concentrations of MPP+ in striatum were lower [16]. Several reports indicated that the loss of dendritic processes in striatum and nigral TH-positive neurons' cell bodies were not permanent and recovery of striatal and nigral TH-immunoreactivity were observed after MPTP is eliminated systemically [42][44]. Such increases in TH-immunoreactivity may reflect sprouting of residual fibers [44] or the de novo appearance of TH-positive neurons in dopamine-depleted striatum [45][47], but more likely represent a compensatory mechanism for chronically reduced dopamine levels as suggested from post-mortem studies of PD brains [48]. Taking into consideration of these reports, we may conclude that the number of TH-positive neurons in chronic MPTP model does not decrease as much as in acute MPTP model because chronic recovery and damage of TH fiber occurred simultaneously in nigro-striatal pathway. Nevertheless, chronic administration induced behavioral impairment. This impairment may be due to degeneration of dopaminergic and noradrenergic neurons, i.e. loss of dopamine and norepinephrine, but not serotonin, from the target areas of the respective neurons. And what is more, chronic neurotoxicity induced formation of neuronal inclusion bodies and degeneration of catecholaminergic neurons, similar to the effects of chronic administration of rotenone which is also a mitochondrial complex I inhibitor [49][51]. Therefore, continuous mitochondrial inhibition may impair the ubiquitin proteasome system, which in turn recreates a disease state that mimics human PD better than acute mitochondrial inhibition.

Dopaminergic lesions induced by MPTP are commonly used to model of PD, and although MPTP effectively mimics the dopaminergic neuropathology of PD in mice, it fails to produce PD-like motor deficits [52]. Although continuous MPTP administration with an osmotic minipump mimics many features of the human disease [16], no significant effects in behavioral impairment except only open-field test showed significant change but not in other test such as rotarod test, tail suspension test, and ring test (data not shown). In acute PD model mice, age-related severity of dopaminergic neurodegeneration and motor dysfunction to MPTP neurotoxicity was reported. Although young (10 weeks) mice showed no mortality in either MPTP treatment, older (14–15 months) mice exhibited mortality from only two injections of MPTP during the experimental period [53]. Though the effects of H2 water on behavioral response were not tested in older mice in the current study, our results raised a possibility that H2 water may reduce the movement disorder in PD patients.

H2 would be also useful for other diseases which are caused by oxidative stress. Already, H2 has been found effective for not only ischemic injury but also hepatic damage and cognitive disease [1][3], [23]. On the other hands, 8-oxoG is accumulated both in nuclear and mitochondrial genomes during aging [54], and dramatic increase in 8-oxoG accumulation was reported in patients with tumors [55] and other kinds of neurodegenerative disease such as PD [56], Alzheimer's disease [57] and amyotrophic lateral sclerosis [58]. Several experiments using genetic knockout mice revealed that the correlation between 8-oxoG accumulation and functional disorder of repair enzymes such as MTH1 [59], MUTYH [60], and OGG1 [61], suggesting that H2 may also suppress tumorigenesis.

H2 gas itself has a risk of flammability and explosion. However, drinking H2 water would be much safer and easier, being more practical. In addition, the required concentration of H2 in drinking water is not necessarily high. Our study also revealed that drinking H2 water even after acute MPTP administration was effective as well. While there is no known way to prevent PD, the current studies strongly suggest that drinking H2 water could reduce the risk of life style-related oxidative stress and related neurodegenerative diseases.

Materials and Methods

Hydrogen-containing water and its H2 content

Hydrogen-containing water (H2 water) was made by two ways. One way was by dissolving H2 gas, produced by electrolysis of water (hand-made by Panasonic Electric Works Co., Ltd., Japan), directly into pure water. Another way was utilizing electrochemical reaction between magnesium and water (H2O): Mg+2H2O→ Mg2++2OH+2H2. A magnesium stick composed of 90% Mg, 9% alminium and 1% zinc (6 mm diameter, 10 cm length, Nakagawa Metal, Japan) was surface-cleaned with 0.1 N acetic acid and dipped into pure water for about 1 minute. The maximum H2 content with this method was about 0.08 ppm, measured with a hydrogen electrode (DH-35A, TOA DKK Co. Ltd., Japan). Electrolyzed H2 water was also adjusted to have 0.08 ppm H2 unless otherwise indicated.

pH of H2 water and Mg(OH)2 solution

The pH of H2 water made by the chemical reaction with Mg was about 8.8 due to the formation of Mg(OH)2, while the pH of pure water was 5.9. To investigate the effect of the alkaline solution (pH 8.8), Mg(OH)2 (∼80 µM) was added to pure water.

Treatment of mice with H2 water

Animal protocols were approved by the Animal Care and Use Committee of Kyushu University. Male C57BL/6J (CLEA Japan Inc., Japan) mice of 8∼12 weeks old were maintained on a 12∶12 h light/dark cycle. H2 water was made freshly each day and 40 ml was delivered in glass bottles with tight rubber caps per 4 mice for 8 h (4–12 p.m.). Unless otherwise indicated, mice were treated with H2 or non-H2 water for 7 days prior to MPTP administration. For MPTP chronic model, treatment with H2 or non-H2 water continued after MPTP administration.

Acute injection and continuous infusion of MPTP

For acute injection of MPTP, MPTP-HCl (20 mg/kg free base, SIGMA, USA) was administrated to mice intraperitoneally (i.p.) three times (2 h apart) and brains were extirpated under anesthesia 48 h after the last MPTP injection. MPTP was dissolved in 0.9% NaCl. For the continuous infusion of MPTP, an osmotic minipump (ALZET model 2004, USA) was transplanted subcutaneously, releasing either saline solution or MPTP solution at 45 mg/kg daily. After implantation, the incision was sutured, and disinfected with 70% ethanol every day. Twenty-eight days after the start of MPTP infusions, brains were extirpated under anesthesia. We checked that no solution was retained in the pump after the brain was removed.

Immunohistochemistry of tyrosine hydroxylase (TH)

TH-positive neurons were stained as described previously [5]. Brain sections (20 and 40 µm thick in SN and striatum, respectively) were incubated in blocking solution (Block Ace, Dainippon Pharmaceutical, Japan) for 30 min at room temperature, and then incubated with primary antibody (rabbit anti-TH antibody; 1∶500, AB152, Chemicon, USA) in 10% Block Ace in PBS, at 4°C overnight. The rinsed sections were immersed in a solution of 3% H2O2 in methanol/PBS (1∶1) for 30 min at room temperature, and then processed by the Vectastain ABC kit (Vector, USA) with secondary antibody (biotinylated anti-rabbit IgG, 1∶200, Vector, USA). The peroxidase reaction product was detected using 3′3′-diaminobenzidine-tetrahydrochloride (DAB, Vector, USA). All sections were then washed in PBS, cover-slipped, and analyzed by AxioSkop2 equipped with with a CCD camera, AxioCam (Carl Zeiss, Germany). The number of dopamine neurons in the SNpc was estimated by counting all TH-positive neurons of two hemispheres from six coronal sections (20 µm thick) per animal that were distributed every 100 µm along the rostral–caudate axis of the SN (−3.08 to −3.64 mm caudal to bregma) [62].

Microglial cells were stained as described in Materials and Methods S1 [References S1].

Stereological analysis of nigral Dopaminergic neuron

We performed stereological analysis using slightly modified method as described previously [63][65]. Coronal sections (30 µm thickness) were obtained through SNpc (−2.70 mm to −3.80 mm relative to bregma) on MICROM cryostat. Free-floating sections were incubated by Block Ace (Dainippon Pharmaceutics, Japan) for 30 min followed by incubation of primary antibody (anti-TH antibody, Chemicon, USA, 1∶3000 in 10% Block Ace) for 2 days at 4°C. After the rinsed sections were immersed in a solution of 3% H2O2 in methanol/PBS (1: 1) for 10 min at room temperature, secondary antibody (biotinylated goat anti-rabbit IgG, 1∶400, Vector, USA) were incubated for 2 h, and then were processed by Vectastain ABC kit (Vector, USA). The peroxidase reaction product was detected using 3′3′-diaminobenzidinetetrahydrochloride (DAB, Vector, USA). All sections were coverslipped with Glycergel Mounting Medium (Dako, Denmark).

For stereological counts, Stereo Investigator analysis software (Stereo Investigator 8, MicroBrightField Inc., USA) was used to perform unbiased stereological counts of TH-immunoreactive cell bodies in the SNpc using optical fractionator method [66]. The boundary of SNpc was outlined under magnification of the 10x objective. Every third section (eight sections per brain) were obtained, and cells were counted with a 40x objective on a Nikon ECLIPSE 80i using a grid of 70×70 µm on a counting grid (75×100×12 µm) with 2 µm upper and lower guard zones. The absolute number of TH-positive neurons was directly calculated, and the Gundersen's coefficient of error in all samples were <0.07.

Labeling of intracellular superoxide in vivo

Intracellular superoxide levels were detected by quantification of fluorescence of the oxidation product of dihydroethidium (DHE, Molecular Probes, USA). Oxidation of DHE by superoxide converts DHE, which exhibits weak blue fluorescence, to an ethidium derivative (oxy-Et) that exhibits peak fluorescence in the rhodamine spectrum (excitation 480 nm, emission 567–586 nm) [20]. DHE, which is cell permeant, enters the cell and, after oxidation, binds to DNA with a small shift in its emission spectrum to 567 nm. DHE has increased specificity for superoxide compared with other dyes which are more general reactive oxygen species probes. DHE solution (200 µl; 1 mg/ml in PBS) was administrated intravenously 5 h before extirpating brain. Brains were sliced into 40 µm thicknesses using a cryostat and free-floating sections were obtained from the part of SN, as mentioned above in TH immunohistochemistry.

For immunofluorescent staining of TH, sections were incubated with Block Ace for 30 min at room temperature. The brain sections were incubated overnight at 4°C with primary antibody, rabbit anti-TH antibody (chemicon, 1∶1000), and incubated for 4 h with Alexa fluor 488 goat anti-rabbit IgG (Molecular Probes, 1∶500, USA) at room temperature. Every treatment was followed by washing three times for 5 min with PBS. Sections were mounted in the permafluor aqueous mounting medium (Thermo, Japan) and were analyzed with a confocal laser scanning microscope (LSM510META, Carl Zeiss, Germany).

Fluorescent labeling of 4-hydroxynonenal in SNpc

For detection of cellular lipid peroxide, we stained 4-hydroxynonenal (4-HNE). Briefly, free-floating sections were obtained from the part of SN, and incubated with primary antibody overnight following to the incubation with Block Ace. Then, sections were incubated with biotinylated anti-mouse IgG (Jackson, USA, 1∶400), followed by streptavidin Alexa 594 (Molecular Probes, USA, 1∶1000). After staining of 4-HNE, TH was stained as described above.

Quantitative analysis of DHE and 4-HNE fluorescent signal

All samples were analyzed with a confocal laser scanning microscope (LSM510META, Carl Zeiss, Germany). For each slice 10 series of z-stack images corresponding to 2 µm on the z-axis were obtained and projected using LSM image browser (Carl Zeiss, Germany). For quantification of fluorescent intensity of DHE and 4-HNE, all images were converted to grayscale, and the average of pixel intensity of each cell was measured using Adobe Photoshop CS3 (Adobe Systems). Over 60 cells which were merged with TH immunofluorescence were observed per animal and mean value of intensity/cell/animal was calculated in each group.

Immunohistochemistry of 8-oxoguanine in striatum

The method of staining 8-oxoG in mitochondrial DNA was described previously [5], [22]. To eliminate cellular RNA, the sections were incubated in 10 mM Tris-HCl (pH 7.5), 15 mM NaCl containing DNase-free RNase (5 mg/ml of heat-incubated RNase A, Sigma, USA) for 60 min at 37°C. In this condition, nuclear DNA is not denatured at all, therefore the anti-8-oxoG antibody cannot access to 8-oxoG residues buried in the intact chromatin in nuclei, while the antibody easily accesses to 8-oxoG residues in mitochondrial DNA which does not have a tight chromatin structure. To detect 8-oxoG in nuclear DNA, section has to be subjected to pre-treatment with 2N HCl for 1 h at room temperature, which allows an efficient denaturation of nuclear chromatin but an extensive degradation of mitochondrial DNA [22]. Free-floating sections pre-treated were incubated in Block Ace, for 30 min at room temperature, and then were incubated with primary antibody (N45.1 mAb 1∶100, Japan Institute for the Control of Aging, Japan) in 10% Block Ace, at 4°C overnight. The rinsed sections were immersed in a solution of 3% H2O2 in methanol/PBS (1: 1) for 15 min at room temperature, and then were processed by Vectastain ABC kit with a biotinylated secondary antibody, and the peroxidase reaction product was detected using DAB. Digital images were acquired using Axioskop2 plus equipped with a CCD camera, AxioCam. All sections from each experimental animal and group to be compared were processed in parallel.

Quantitative morphometric analysis of 8-oxoG

All acquired digital images were processed uniformly, as described previously [5], at a threshold in a gray scale mode to subtract any background corresponding to the area without tissue, and the optical density (OD) of each immunoreactive area was calculated by Adobe Photoshop version 7.0 (Adobe Systems). From each individual animal, five representative sections were measured and the mean OD was calculated as an immunoreactivity index for each animals. All quantitative analyses were performed by an individual unaware of the experimental treatments.

Open-field test for continuous MPTP infusion model mice

Before and 28 days after osmotic pumps were implanted, open-field tests were performed between 9 and 12 AM. A round open field with 60 cm in base diameter and 90 cm in upper diameter, surrounded by a 50 cm-high wall was used. During observation, a 100 W lamp-light was placed 80 cm above the field. Each mouse was put at the center of the field and the movements were recorded. Each mouse was tested for 3 min and the number of times they crossed a line drawn in the field was counted (modified from the method described previously [67]).

MPP+ measurement

HPLC-UV detection (wavelength, 295 nm) was used to measure 1-methyl-4-phenylpyridinium (MPP+, SIGMA, USA) levels in striatum using the method as described previously [68], [69]. Mouse brains were subjected to be measured 1.5, 3, 6 h after MPTP was treated (n = 4). The standard solution of MPP+ (500 nM) was made by dilution of MPP+ stock solution (1 mM in 20% glycerol, 2.5% MeOH in pure water, pH 4.0 with H3PO4).

Statistical Analysis

All data represent mean±standard error of means (SEM). The data were compared with one-way ANOVA, followed by Bonferroni test. Values of p <0.05 were considered statistically significant.

Supporting Information

Figure S1.

Immunohistochemistry of microglia in substantia nigra. Mice drinking non-H2 water (H2(−)) or H2 water (H2(+)) were treated with saline or MPTP. Brains were obtained 24 h or 48 h after the last injection of saline or MPTP. Microglial cells were immunostained with anti-Iba1 antibody (1∶1000, WAKO). Scale: 50 µm.

https://doi.org/10.1371/journal.pone.0007247.s001

(3.97 MB TIF)

Figure S2.

Representative concentration curve of H2 in striatum. Anesthetized rats were inserted H2 electrode to right striatum and currents were recorded by voltammetry. Rats started to inhale H2 gas at 200 s after the start of recording, and stopped at 800 s.

https://doi.org/10.1371/journal.pone.0007247.s002

(0.39 MB TIF)

Acknowledgments

We would like to thank Setsuko Kitamura, for her technical assistance, and Prof. David. A. Brown (UCL, UK) for discussion.

Author Contributions

Conceived and designed the experiments: YN MN. Performed the experiments: KF TS NY HY KS YY. Analyzed the data: KF TS HY YY. Contributed reagents/materials/analysis tools: MO HY MAK AT TK YT. Wrote the paper: KF YN MN. Undertook most of the experiments and wrote the manuscript: KF. Established MPTP-induced PD model mice: TS. Performed stereological analysis: NY. Contributed the generation of MPTP-induced PD model mice and behavioral analyses: HY HY. Contributed stereological analysis: KS. Contributed immunohistochemistry: MO YY MAK. Contributed to making H2 water: AT. Contributed H2 measurements: YK YT.

References

  1. 1. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, et al. (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13: 688–694.I. OhsawaM. IshikawaK. TakahashiM. WatanabeK. Nishimaki2007Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.Nat Med13688694
  2. 2. Cai J, Kang Z, Liu WW, Luo X, Qiang S, et al. (2008) Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett 441: 167–172.J. CaiZ. KangWW LiuX. LuoS. Qiang2008Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model.Neurosci Lett441167172
  3. 3. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S (2009) Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology 34: 501–8.K. NagataN. Nakashima-KamimuraT. MikamiI. OhsawaS. Ohta2009Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice.Neuropsychopharmacology345018
  4. 4. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, et al. (2008) Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun 375: 346–50.Y. SatoS. KajiyamaA. AmanoY. KondoT. Sasaki2008Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice.Biochem Biophys Res Commun37534650
  5. 5. Yamaguchi H, Kajitani K, Dan Y, Furuichi M, Ohno M, et al. (2006) MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Cell Death Differ 13: 551–563.H. YamaguchiK. KajitaniY. DanM. FuruichiM. Ohno2006MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Cell Death Differ13551563
  6. 6. Thomas B, Beal MF (2007) Parkinson's disease. Hum Mol Genetics 16: R183–194.B. ThomasMF Beal2007Parkinson's disease.Hum Mol Genetics16R183194
  7. 7. Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7: 97–109.AH Schapira2008Mitochondria in the aetiology and pathogenesis of Parkinson's disease.Lancet Neurol797109
  8. 8. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123–144.CW OlanowWG Tatton1999Etiology and pathogenesis of Parkinson's disease.Annu Rev Neurosci22123144
  9. 9. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889–909.W. DauerS. Przedborski2003Parkinson's disease: mechanisms and models.Neuron39889909
  10. 10. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A 82: 2173–2177.JA JavitchRJ D'AmatoSM StrittmatterSH Snyder1985Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proc Natl Acad Sci U S A8221732177
  11. 11. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE (1987) MPTP, MPP+ and Mitochondrial Function. Life Sci 40: 721–729.WJ NicklasSK YoungsterMV KindtRE Heikkila1987MPTP, MPP+ and Mitochondrial Function.Life Sci40721729
  12. 12. Liang LP, Huang J, Fulton R, Day BJ, Patel M (2007) An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo. J Neurosci 27: 4326–4333.LP LiangJ. HuangR. FultonBJ DayM. Patel2007An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo.J Neurosci2743264333
  13. 13. Zhang W, Wang T, Qin L, Gao HM, Wilson B, et al. (2004) Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J 18: 589–591.W. ZhangT. WangL. QinHM GaoB. Wilson2004Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.FASEB J18589591
  14. 14. Yanagihara T, Arai K, Miyamae K, Sato B, Shudo T, et al. (2005) Electrolyzed hydrogen-saturated water for drinking use elicits an antioxidative effect: a feeding test with rats. Biosci Biotechnol Biochem 69: 1985–1987.T. YanagiharaK. AraiK. MiyamaeB. SatoT. Shudo2005Electrolyzed hydrogen-saturated water for drinking use elicits an antioxidative effect: a feeding test with rats.Biosci Biotechnol Biochem6919851987
  15. 15. Langston JW (2002) The Impact of MPTP on Parkinson's Disease Research: Past, Present, and Future. In: Factor SA, Weiner WJ, editors. Parkinson's Disease. xx. Diagnosis and Clinical Management: Demos Medical Publishing. JW Langston2002The Impact of MPTP on Parkinson's Disease Research: Past, Present, and Future.SA FactorWJ WeinerParkinson's DiseasexxDiagnosis and Clinical ManagementDemos Medical Publishing
  16. 16. Fornai F, Schlüter OM, Lenzi P, Gesi M, Ruffoli R, et al. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102: 3413–3418.F. FornaiOM SchlüterP. LenziM. GesiR. Ruffoli2005Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.Proc Natl Acad Sci U S A10234133418
  17. 17. Stadler K, Bonini MG, Dallas S, Jiang J, Radi R, et al. (2008) Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radic Biol Med 45: 866–874.K. StadlerMG BoniniS. DallasJ. JiangR. Radi2008Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes.Free Radic Biol Med45866874
  18. 18. Awasthi YC, Sharma R, Sharma A, Yadav S, Singhal SS, et al. (2008) Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. Free Radic Biol Med 45: 111–118.YC AwasthiR. SharmaA. SharmaS. YadavSS Singhal2008Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death.Free Radic Biol Med45111118
  19. 19. Selley ML (1998) (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 25: 169–174.ML Selley1998(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease.Free Radic Biol Med25169174
  20. 20. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, et al. (2003) Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359–1368.H. ZhaoS. KalivendiH. ZhangJ. JosephK. Nithipatikom2003Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide.Free Radic Biol Med3413591368
  21. 21. Oka S, Ohno M, Tsuchimoto D, Sakumi K, Furuichi M, et al. (2008) Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J 27: 421–432.S. OkaM. OhnoD. TsuchimotoK. SakumiM. Furuichi2008Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs.EMBO J27421432
  22. 22. Ohno M, Oka S, Nakabeppu Y (2009) Quantitative analysis of oxidized Guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method. Methods Mol Biol 554: 199–212.M. OhnoS. OkaY. Nakabeppu2009Quantitative analysis of oxidized Guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method.Methods Mol Biol554199212
  23. 23. Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47: S161–170.P. JennerCW Olanow1996Oxidative stress and the pathogenesis of Parkinson's disease.Neurology47S161170
  24. 24. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14: 633–643.DG Graham1978Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.Mol Pharmacol14633643
  25. 25. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, et al. (2007) Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun 361: 670–674.K. FukudaS. AsohM. IshikawaY. YamamotoI. Ohsawa2007Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress.Biochem Biophys Res Commun361670674
  26. 26. Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, et al. (2008) Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 373: 30–35.K. HayashidaM. SanoI. OhsawaK. ShinmuraK. Tamaki2008Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury.Biochem Biophys Res Commun3733035
  27. 27. Ooboshi H, Sadoshima S, Ibayashi S, Yao H, Uchimura H, et al. (1993) Isradipine attenuates the ischemia-induced release of dopamine in the striatum of the rat. Eur J Pharmacol 233: 165–168.H. OoboshiS. SadoshimaS. IbayashiH. YaoH. Uchimura1993Isradipine attenuates the ischemia-induced release of dopamine in the striatum of the rat.Eur J Pharmacol233165168
  28. 28. Katafuchi T, Oomura Y, Yoshimatsu H (1985) Single neuron activity in the rat lateral hypothalamus during 2-deoxy-D-glucose induced and natural feeding behavior. Brain Res 359: 1–9.T. KatafuchiY. OomuraH. Yoshimatsu1985Single neuron activity in the rat lateral hypothalamus during 2-deoxy-D-glucose induced and natural feeding behavior.Brain Res35919
  29. 29. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, et al. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12: 1658–1667.S. PrzedborskiV. KosticV. Jackson-LewisAB NainiS. Simonetti1992Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.J Neurosci1216581667
  30. 30. Lotharius J, O'Malley KL (2000) The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275: 38581–38588.J. LothariusKL O'Malley2000The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.J Biol Chem2753858138588
  31. 31. Hasegawa E, Takeshige K, Oishi T, Murai Y, Minakami S (1990) 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170: 1049–1055.E. HasegawaK. TakeshigeT. OishiY. MuraiS. Minakami19901-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles.Biochem Biophys Res Commun17010491055
  32. 32. Klivenyi P, St Clair D, Wermer M, Yen HC, Oberley T, Y , et al. (1998) Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol Dis 5: 253–258.P. KlivenyiD. St ClairM. WermerHC YenT. OberleyY1998Manganese superoxide dismutase overexpression attenuates MPTP toxicity.Neurobiol Dis5253258
  33. 33. Greenamyre JT, Sherer TB, Betarbet R, Panov AV (2001) Complex I and Parkinson's disease. IUBMB Life 52: 135–141.JT GreenamyreTB ShererR. BetarbetAV Panov2001Complex I and Parkinson's disease.IUBMB Life52135141
  34. 34. Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 2: 119–130.MF Beal1992Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Ann Neurol2119130
  35. 35. Gutteridge JM (1992) Iron and oxygen radicals in brain. Ann. Neurol 32: S16–21.JM Gutteridge1992Iron and oxygen radicals in brain. Ann.Neurol32S1621
  36. 36. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37: 899–909.D. KaurF. YantiriS. RajagopalanJ. KumarJQ Mo2003Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.Neuron37899909
  37. 37. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, et al. (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318: 1645–1647.MM BehrensSS AliDN DaoJ. LuceroG. Shekhtman2007Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase.Science31816451647
  38. 38. Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, et al. (2006) Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci U S A 103: 15038–15043.KM RobinsonMS JanesM. PeharJS MonetteMF Ross2006Selective fluorescent imaging of superoxide in vivo using ethidium-based probes.Proc Natl Acad Sci U S A1031503815043
  39. 39. Chiba Y, Yamashita Y, Ueno M, Fujisawa H, Hirayoshi K, et al. (2005) Cultured murine dermal fibroblast-like cells from senescence-accelerated mice as in vitro models for higher oxidative stress due to mitochondrial alterations. J Gerontol A Biol Sci Med Sci 60: 1087–1098.Y. ChibaY. YamashitaM. UenoH. FujisawaK. Hirayoshi2005Cultured murine dermal fibroblast-like cells from senescence-accelerated mice as in vitro models for higher oxidative stress due to mitochondrial alterations.J Gerontol A Biol Sci Med Sci6010871098
  40. 40. Drukarch B, van Muiswinkel FL (2001) Neuroprotection for Parkinson's disease: A new approach for a new millennium. Expert Opin Investig Drugs 10: 1855–1868.B. DrukarchFL van Muiswinkel2001Neuroprotection for Parkinson's disease: A new approach for a new millennium.Expert Opin Investig Drugs1018551868
  41. 41. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, et al. (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 100: 6145–6150.DC WuP. TeismannK. TieuM. VilaV. Jackson-Lewis2003NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.Proc Natl Acad Sci U S A10061456150
  42. 42. Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106: 589–601.E. PetroskeGE MeredithS. CallenS. TotterdellYS Lau2001Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.Neuroscience106589601
  43. 43. Mitsumoto Y, Watanabe A, Mori A, Koga N (1998) Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice. Biochem Biophys Res Commun 248: 660–663.Y. MitsumotoA. WatanabeA. MoriN. Koga1998Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.Biochem Biophys Res Commun248660663
  44. 44. Song DD, Haber SN (2000) Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J Neurosci 20: 5102–5114.DD SongSN Haber2000Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.J Neurosci2051025114
  45. 45. Du X, Stull ND, Iacovitti L (1995) Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons. Brain Res 680: 229–233.X. DuND StullL. Iacovitti1995Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neurons.Brain Res680229233
  46. 46. Betarbet R, Turner R, Chockkan V, DeLong MR, Allers KA, et al. (1997) Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17: 6761–6768.R. BetarbetR. TurnerV. ChockkanMR DeLongKA Allers1997Dopaminergic neurons intrinsic to the primate striatum.J Neurosci1767616768
  47. 47. Meredith GE, Farrell T, Kellaghan P, Tan Y, Zahm DS, et al. (1999) Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions. Eur J Neurosci 11: 3585–3596.GE MeredithT. FarrellP. KellaghanY. TanDS Zahm1999Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions.Eur J Neurosci1135853596
  48. 48. Grima B, Lamouroux A, Boni C, Julien JF, Javoy-Agid F, et al. (1987) A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326: 707–711.B. GrimaA. LamourouxC. BoniJF JulienF. Javoy-Agid1987A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics.Nature326707711
  49. 49. Greenamyre JT, Hastings TG (2004) Biomedicine. Parkinson's–divergent causes, convergent mechanisms. Science 304: 1120–1122.JT GreenamyreTG Hastings2004Biomedicine. Parkinson's–divergent causes, convergent mechanisms.Science30411201122
  50. 50. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301–1306.R. BetarbetTB ShererG. MacKenzieM. Garcia-OsunaAV Panov2000Chronic systemic pesticide exposure reproduces features of Parkinson's disease.Nat Neurosci313011306
  51. 51. Höglinger GU, Carrard G, Michel PP, Medja F, Lombès A, et al. (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J Neurochem 86: 1297–1307.GU HöglingerG. CarrardPP MichelF. MedjaA. Lombès2003Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.J Neurochem8612971307
  52. 52. Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, et al. (2007) Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci USA 104: 13804–13809.KS RommelfangerGL EdwardsKG FreemanLC LilesGW Miller2007Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.Proc Natl Acad Sci USA1041380413809
  53. 53. Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M (2006) Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Neurosci Lett 401: 183–187.S. OhashiA. MoriN. KuriharaY. MitsumotoM. Nakai2006Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.Neurosci Lett401183187
  54. 54. Shigenaga MK, Hagen TM, Ames BN (1994) Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91: 10771–10778.MK ShigenagaTM HagenBN Ames1994Oxidative damage and mitochondrial decay in aging.Proc Natl Acad Sci USA911077110778
  55. 55. Iida T, Furuta A, Kawashima M, Nishida J, Nakabeppu Y, et al. (2001) Accumulation of 8-oxo-2′-deoxyguanosine and increased expression of hMTH1 protein in brain tumors. Neuro-oncol 3: 73–81.T. IidaA. FurutaM. KawashimaJ. NishidaY. Nakabeppu2001Accumulation of 8-oxo-2′-deoxyguanosine and increased expression of hMTH1 protein in brain tumors.Neuro-oncol37381
  56. 56. Shimura-Miura H, Hattori N, Kang D, Miyako K, Nakabeppu Y, et al. (1999) Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease. Ann Neurol 46: 920–924.H. Shimura-MiuraN. HattoriD. KangK. MiyakoY. Nakabeppu1999Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease.Ann Neurol46920924
  57. 57. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759–767.A. NunomuraG. PerryG. AlievK. HiraiA. Takeda2001Oxidative damage is the earliest event in Alzheimer disease.J Neuropathol Exp Neurol60759767
  58. 58. Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, et al. (2002) Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis. Acta Neuropathol 103: 408–414.H. KikuchiA. FurutaK. NishiokaSO SuzukiY. Nakabeppu2002Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis.Acta Neuropathol103408414
  59. 59. Tsuzuki T, Egashira A, Igarashi H, Iwakuma T, Nakatsuru Y, et al. (2001) Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc Natl Acad Sci U S A 98: 11456–11461.T. TsuzukiA. EgashiraH. IgarashiT. IwakumaY. Nakatsuru2001Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase.Proc Natl Acad Sci U S A981145611461
  60. 60. Sakamoto K, Tominaga Y, Yamauchi K, Nakatsu Y, Sakumi K, et al. (2007) MUTYH-null mice are susceptible to spontaneous and oxidative-stress-induced intestinal tumorigenesis. Cancer Res 67: 6599–6604.K. SakamotoY. TominagaK. YamauchiY. NakatsuK. Sakumi2007MUTYH-null mice are susceptible to spontaneous and oxidative-stress-induced intestinal tumorigenesis.Cancer Res6765996604
  61. 61. Sakumi K, Tominaga Y, Furuichi M, Xu P, Tsuzuki T, et al. (2003) Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 63: 902–905.K. SakumiY. TominagaM. FuruichiP. XuT. Tsuzuki2003Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption.Cancer Res63902905
  62. 62. Franklin KB, Paxinos G (2001) The Mouse Brain in Stereotaxic Coordinates (New York: Academic Press). KB FranklinG. Paxinos2001The Mouse Brain in Stereotaxic Coordinates (New York: Academic Press)
  63. 63. Kajitani K, Nomaru H, Ifuku M, Yutsudo N, Dan Y, et al. (2009) Galectin-1 promotes basal and kainate-induced proliferation of neural progenitors in the dentate gyrus of adult mouse hippocampus. Cell Death Differ 16: 417–27.K. KajitaniH. NomaruM. IfukuN. YutsudoY. Dan2009Galectin-1 promotes basal and kainate-induced proliferation of neural progenitors in the dentate gyrus of adult mouse hippocampus.Cell Death Differ1641727
  64. 64. Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, et al. (2008) MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS One 3: e1616.JK MallajosyulaD. KaurSJ ChintaS. RajagopalanA. Rane2008MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.PLoS One3e1616
  65. 65. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, et al. (2007) Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27: 3328–37.MP MountA. LiraD. GrimesPD SmithS. Faucher2007Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.J Neurosci27332837
  66. 66. West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231: 482–497.MJ WestL. SlomiankaHJ Gundersen1991Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator.Anat Rec231482497
  67. 67. Crabbe JC, Rigter H, Kerbusch S (1982) Analysis of behavioural responses to an ACTH analog in CXB/By recombinant inbred mice. Behav Brain Res 4: 289–314.JC CrabbeH. RigterS. Kerbusch1982Analysis of behavioural responses to an ACTH analog in CXB/By recombinant inbred mice.Behav Brain Res4289314
  68. 68. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, et al. (1996) Role of neuronal nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93: 4565–4571.S. PrzedborskiV. Jackson-LewisR. YokoyamaT. ShibataVL Dawson1996Role of neuronal nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity.Proc Natl Acad Sci USA9345654571
  69. 69. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, et al. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5: 1403–1409.GT LiberatoreV. Jackson-LewisS. VukosavicAS MandirM. Vila1999Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.Nat Med514031409